Sfoglia per AUTORE
IURLO A
Collezione AO Ordine Mauriziano

  

Items : 10

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study. in European journal of haematology / Eur J Haematol. 2025 Jan;114(1):37-44. doi: 10.1111/ejh.14299. Epub 2024 Sep 12.
2025
AO Cuneo
AO Ordine Mauriziano

Bocchia M; Galimberti S; Vincelli DI; Luzi D; Rapezzi D; Sancetta R; Murgano P; Crugnola M; Stagno F; Maggi A; Leporace AP; Scortechini AR; Di Veroli A; Crisà E; Sportoletti P; Binotto G; Attolico I; Mullai R; Lunghi F; Elena C; Loglisci G; Caocci G; Luciano L; Bonifacio M; Sorà F; Annunziata M; Carmosino I; Russo S; Crescenzi SL; et alii...

Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey. in Journal of clinical medicine / J Clin Med. 2023 Aug 13;12(16):5267. doi: 10.3390/jcm12165267.
2023
AO Ordine Mauriziano

Breccia M; Piciocchi A; Abruzzese E; Cilloni D; Messina M; Soddu S; Castagnetti F; Stagno F; Fazi P; Iurlo A; Caocci G; Gozzini A; Intermesoli T; D'Adda M; Pane F;

Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia. in Cell death & disease / Cell Death Dis. 2022 Jun 30;13(6):576. doi: 10.1038/s41419-022-05028-9.
2022
AOU Alessandria
AO Ordine Mauriziano

Oliviero S; Taverna D; Castagnetti F; Caocci G; Mulas O; Breccia M; Abruzzese E; Iurlo A; Sora F; Geuna M; Gai M; Passoni A; Fava C; Boschi D; Giorgis M; Gaidano V; Sainas S; Molineris I; Cignetti A; Orso F; Vitale N; Houshmand M; Pane F; Lolli ML; Circosta P; Saglio G;

Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome. in Cancers / Cancers (Basel). 2021 Mar 15;13(6):1311. doi: 10.3390/cancers13061311.
2021
AOU Alessandria
AO Ordine Mauriziano

Iurlo A; Stagno F; Pregno P; Martino B; Bonifacio M; Binotto G; Bocchia M; Specchia G; Luciano L; Annunziata M; Galimberti S; Pungolino E; Nikougoftar Zarif M; Fava C; Spinelli M; Cignetti A; Gaidano V; Stefania R; Garello F; Houshmand M; Russo S; Aime S; Circosta P; Saglio G; Houshmand M; Garello F; Stefania R; Gaidano V; Cignetti A; et alii...

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.
2020
AO Ordine Mauriziano

Soverini S; Bavaro L; De Benedittis C; Martelli M; Iurlo A; Orofino N; Sica S; Sorà F; Lunghi F; Ciceri F; Galimberti S; Baratè C; Bonifacio M; Scaffidi L; Castagnetti F; Gugliotta G; Albano F; Russo Rossi AV; Stagno F; di Raimondo F; D'Adda M; di Bona E; Abruzzese E; Binotto G; Sancetta R; Salvucci M; Capodanno I; Girasoli M; Coluzzi S; et alii...

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper. in Journal of hematology & oncology / J Hematol Oncol. 2019 Dec 5;12(1):131. doi: 10.1186/s13045-019-0815-5.
2019
AO Ordine Mauriziano

Soverini S; Abruzzese E; Bocchia M; Bonifacio M; Galimberti S; Gozzini A; Iurlo A; Luciano L; Pregno P; Rosti G; Saglio G; Stagno F; Tiribelli M; Vigneri P; Barosi G; Breccia M;

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.
2018
AO Ordine Mauriziano

Iurlo A; Galimberti S; Abruzzese E; Annunziata M; Bonifacio M; Latagliata R; Pregno P; Ferrero D; Sorà F; Orlandi EM; Fava C; Cattaneo D; Bucelli C; Binotto G; Pungolino E; Tiribelli M; Gozzini A; Gugliotta G; Castagnetti F; Stagno F; Rege-Cambrin G; Martino B; Luciano L; Breccia M; Sica S; Bocchia M; Pane F; Saglio G; Rosti G; et alii...

Residual Peripheral Blood CD26(+) Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission. in Frontiers in oncology / Front Oncol. 2018 May 30;8:194. doi: 10.3389/fonc.2018.00194. eCollection 2018.
2018
AO Ordine Mauriziano

Bocchia M; Sicuranza A; Abruzzese E; Iurlo A; Sirianni S; Gozzini A; Galimberti S; Aprile L; Martino B; Pregno P; Sorà F; Alunni G; Fava C; Castagnetti F; Puccetti L; Breccia M; Cattaneo D; Defina M; Mulas O; Baratè C; Caocci G; Sica S; Gozzetti A; Luciano L; Crugnola M; Annunziata M; Tiribelli M; Pacelli P; Ferrigno I; et alii...

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia. in Oncotarget / Oncotarget. 2017 Sep 30;8(50):88021-88033. doi: 10.18632/oncotarget.21406. eCollection 2017 Oct 20.
2017
AO Ordine Mauriziano

Galimberti S; Bucelli C; Arrigoni E; Baratè C; Grassi S; Ricci F; Guerrini F; Ciabatti E; Fava C; D'Avolio A; Fontanelli G; Cambrin GR; Isidori A; Loscocco F; Caocci G; Greco M; Bocchia M; Aprile L; Gozzini A; Scappini B; Cattaneo D; Scortechini AR; La Nasa G; Bosi A; Leoni P; Danesi R; Saglio G; Visani G; Cortelezzi A; et alii...

The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib. in American journal of hematology / Am J Hematol. 2017 Aug;92(8):797-805. doi: 10.1002/ajh.24774. Epub 2017 May 30.
2017
AO Ordine Mauriziano

Castagnetti F; Gugliotta G; Breccia M; Iurlo A; Levato L; Albano F; Vigneri P; Abruzzese E; Rossi G; Rupoli S; Cavazzini F; Martino B; Orlandi E; Pregno P; Annunziata M; Usala E; Tiribelli M; Sica S; Bonifacio M; Fava C; Gherlinzoni F; Bocchia M; Soverini S; Bochicchio MT; Cavo M; Giovanni M; Saglio G; Pane F; Baccarani M; et alii...

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte